Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $7.4488 (1.21%) ($7.3944 - $7.7600) on Mon. Apr. 22, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.25% (three month average) | RSI | 64 | Latest Price | $7.4488(1.21%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EYES declines -3.4% a day on average for past five trading days. | Weekly Trend | EYES advances 8.2% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) TAN(9%) UUP(9%) ICLN(6%) UNG(6%) FIVG(5%) | Factors Impacting EYES price | EYES will decline at least -2.625% in a week (0% probabilities). BND(-9%) VCIT(-6%) LQD(-6%) XLP(-5%) TIP(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.625% (StdDev 5.25%) | Hourly BBV | 0 () | Intraday Trend | 0.1% | | | |
|
5 Day Moving Average | $8.02(-7.12%) | 10 Day Moving Average | $8.07(-7.7%) | 20 Day Moving Average | $7.34(1.48%) | To recent high | -18.3% | To recent low | 35.9% | Market Cap | $2.379b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |